Nilotinib: a phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases

Author: Quintáás-Cardama Alfonso   Cortes Jorge  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.4, Iss.5, 2008-10, pp. : 611-621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content